Core Viewpoint - The company, Borui Biopharmaceutical (Suzhou) Co., Ltd., has decided to terminate its plan for a specific issuance of A-shares for the year 2024 and has withdrawn its application documents [1] Group 1 - The fourth meeting of the fourth board of directors was held to review and approve the resolution to terminate the issuance of A-shares [1] - Related director Yuan Jiandong abstained from voting on the resolution [1] - The company and its sponsor, Guolian Minsheng Securities Co., Ltd., submitted applications to the Shanghai Stock Exchange to withdraw the application documents and revoke the sponsorship work [1] Group 2 - On October 21, the company announced that it had received a decision from the Shanghai Stock Exchange to terminate the review of its specific issuance of shares [1] - The Shanghai Stock Exchange made this decision based on relevant regulations [1]

Core Points - The Beijing Stock Exchange has decided to terminate the review of Fujian Guohang Ocean Transportation (Group) Co., Ltd.'s application for a specific object stock issuance [1][2] - The company submitted its application on January 6, 2025, and later withdrew it on September 26, 2025 [2] - The total amount of funds intended to be raised from the issuance was not to exceed 460 million RMB, aimed at supplementing working capital and low-carbon smart ship acquisition projects [2][3] Company Information - Fujian Guohang Ocean Transportation (Group) Co., Ltd. was established in 2001 and is primarily engaged in maritime transportation [5] - The company has a registered capital of 5,554.07453 million RMB and a paid-in capital of 180.6 million RMB [5] - As of the date of the fundraising prospectus, the controlling shareholder is Wang Yanping, who directly holds 31.72% of the company's shares, with family members also holding significant stakes [4]

Core Viewpoint - The company, Bofei Electric (001255.SZ), has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific stock issuance to designated objects, indicating a positive step in its capital raising efforts [1] Group 1 - The company received a notice from the Shenzhen Stock Exchange on October 16, 2025, regarding the acceptance of its application for issuing stocks to specific objects [1] - The Shenzhen Stock Exchange has verified that the application documents submitted by the company are complete and has decided to accept the application [1]

Core Points - Shanghai Yashi Investment Development Co., Ltd. has completed the issuance of shares to specific investors, with the total amount raised being approximately 300 million RMB [4] - The company has signed a tripartite supervision agreement for the storage of raised funds to ensure proper management and usage [5][7] Group 1: Issuance Details - The company issued 43,668,122 shares at a price of 6.87 RMB per share, raising a total of 299,999,998.14 RMB, with a net amount of 297,224,839.53 RMB after deducting issuance costs [4] - The issuance has been approved by the China Securities Regulatory Commission [4] Group 2: Fund Management - A special account for the raised funds has been established at CITIC Bank Shanghai Branch, with a balance of approximately 298.2 million RMB as of October 10, 2025 [6] - The tripartite agreement involves the company, CITIC Bank, and Guolian Minsheng Securities, ensuring that the funds are used solely for designated projects and not for other purposes [5][6] - The agreement stipulates that Guolian Minsheng Securities will supervise the usage of the funds and has the right to conduct audits and inquiries [7][8]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605333 证券简称：沪光股份 公告编号：2025-059 昆山沪光汽车电器股份有限公司 向特定对象发行股票结果暨股本变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 发行数量：27,264,325股； ● 发行价格：32.46元/股； ● 预计上市时间：昆山沪光汽车电器股份有限公司（以下简称"发行人"、"公司"或"沪光股份"）本次向 特定对象发行股票（以下简称"本次发行"）新增的27,264,325股，股份已于2025年10月15日在中国证券 登记结算有限责任公司上海分公司办理完毕登记、托管及限售手续。公司本次发行新增股份为有限售条 件流通股，预计将于6个月限售期满后的次一交易日在上海证券交易所（以下简称"上交所"）上市流通 交易，如遇法定节假日或休息日，则顺延至其后的第一个交易日。限售期届满后的转让和交易将按中国 证券监督管理委员会（以下简称"中国证监会"）及上交所的有关规定执行。本次发行对象所认购的股份 因公司分配股票股利、资本公 ...

Group 1 - The stock of Zhiyuan Interconnect (688369.SH) closed at 24.00 yuan, with a decline of 4.50%, currently in a broken state [1] - Zhiyuan Interconnect was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 31, 2019, with an issuance of 19,250,000 shares at a price of 49.39 yuan per share [1] - The total amount raised from the initial public offering was 950.7575 million yuan, with a net amount of 840.6460 million yuan, exceeding the originally planned fundraising by 49.12729 million yuan [1] Group 2 - The company announced a cash dividend of 3 yuan (including tax) for every 10 shares and a capital reserve conversion of 4.9 shares for every 10 shares, with the record date on June 15, 2023 [2] - Zhiyuan Interconnect plans to issue convertible bonds to unspecified objects, raising up to 703.8650 million yuan, with net proceeds intended for various projects including AICOP R&D and working capital [2] - The company received authorization from the shareholders' meeting to issue stock to specific objects, with a total financing amount not exceeding 300 million yuan, representing no more than 20% of the net assets at the end of the most recent year [2][3]

Core Points - The company has decided to cancel the supervisory board and amend its articles of association to enhance corporate governance and compliance with relevant laws [1][9] - The board meeting was held on October 15, 2025, with all nine directors present, and the resolutions were passed unanimously [2][7] - The company plans to extend the validity period of the resolution regarding the issuance of shares to specific targets for an additional 12 months, until November 26, 2026 [17] Group 1 - The board approved the proposal to cancel the supervisory board, transferring its powers to the audit committee of the board [1][9] - The proposal to amend, establish, and abolish certain governance systems was also approved [4][12] - The resolutions from the board meeting will be submitted to the shareholders' meeting for further approval [3][11] Group 2 - The company has scheduled its first extraordinary shareholders' meeting for 2025 on October 31, 2025 [20] - The meeting will utilize both on-site and online voting methods, with specific time frames for participation [21][22] - Shareholders must register for the meeting in advance, with detailed instructions provided for attendance [25][29]

Meeting Overview - The third extraordinary general meeting of shareholders of Jiangxi Baitong Energy Co., Ltd. was held on October 15, 2025, with both on-site and online voting options available [1][3][4] - A total of 235 shareholders and representatives attended the meeting, representing 17,232,805 shares with voting rights, which is 3.7389% of the total voting shares [5][6] Voting Results - The proposal regarding the company's compliance with conditions for issuing shares to specific targets was approved with 80.9561% of the votes in favor [8] - The proposal for the 2025 stock issuance plan (revised) was also approved with 81.4662% of the votes in favor [9] - The proposal for the issuance method and timing received 81.4963% approval [10] - The proposal regarding the issuance objects and subscription methods was approved with 81.4963% of the votes [11] - The proposal for the number of shares to be issued was approved with 81.4662% of the votes [13] - The proposal regarding the lock-up period received 81.4876% approval [14] - The proposal for the amount and use of raised funds was approved with 81.5515% of the votes [15] - The proposal for the arrangement of undistributed profits before issuance was approved with 81.5404% of the votes [16] - The proposal regarding the effective period of the resolutions received 81.3356% approval [18] - The proposal for the 2025 stock issuance feasibility analysis report was approved with 81.4963% of the votes [19] - The proposal for the stock issuance analysis report was also approved with 81.4963% of the votes [21] - The proposal regarding the dilution of immediate returns and measures to compensate was approved with 81.5497% of the votes [22] - The proposal for the previous fundraising usage report was approved with 81.5613% of the votes [23] - The proposal for signing conditional share subscription agreements with specific targets was approved with 81.4963% of the votes [24] - The proposal for signing supplementary agreements regarding share subscription was approved with 81.4963% of the votes [25] - The proposal for exempting the controlling shareholder from mandatory tender offers was approved with 81.5033% of the votes [26] - The proposal for the shareholder return plan for 2025-2027 was approved with 81.6820% of the votes [28] - The proposal for authorizing the board to handle matters related to the stock issuance was approved with 81.4662% of the votes [29] Legal Compliance - The meeting was conducted in accordance with the Company Law and relevant regulations, with the legal opinions confirming the legality and validity of the meeting and voting procedures [31]

Core Viewpoint - The company will resume trading on October 16, 2025, following the signing of a conditional stock subscription agreement with Xinjiang Bingxin Jian Partnership, which plans to acquire up to 30% of the company's total shares before the issuance [1] Group 1 - The company has signed a stock subscription agreement to issue shares to specific investors, with a maximum of 118 million shares to be held by Xinjiang Bingxin Jian Partnership [1] - The controlling shareholder of the company will change to Xinjiang Bingxin Jian Partnership after the transaction is completed [1] - The actual controller will shift to the Silk Road Financial Development Promotion Center of the Fourth Division of Keke Dara City [1] Group 2 - Shi Weidong has agreed to waive all voting rights associated with his shares in the company for a period of 36 months from the completion of stock registration [1] - The agreement includes a cooperation agreement and provisions related to the waiver of voting rights and stabilization of control [1]

点击查看公告原文>> 登录新浪财经APP 搜索【信披】查看更多考评等级 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 9月5日，神州细胞收到上交所出具的《关于北京神州细胞生物技术集团股份公司向特定对象发行股票申 请文件的审核问询函》。10月15日，公司披露对该审核问询函的回复。 责任编辑：小浪快报 据公告，神州细胞会同相关中介机构对审核问询函所列问题进行研究落实，结合2025年半年度财务报告 更新申请文件，并按要求对有关问题说明论证。相关回复及申请文件已公开披露。 不过，公司本次向特定对象发行股票事项，尚需通过上交所审核，并获得中国证监会同意注册决定方可 实施。最终能否通过上交所审核并获得中国证监会同意注册及其时间，均存在不确定性。公司将及时履 ...